# ClinicalTrials.gov record NCT00005006

> PeptideScanner retained ClinicalTrials.gov record NCT00005006 at 2026-07-30T21:41:27.764Z. Its registry update date was 2015-08-19, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct00005006-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2015-08-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00005006-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00005006-teriparatide-v1.json
- Content SHA-256: `8afb1233b4a0726c0125905d67caf2994fb6c467fa963c06d8c4d13b5649a4a3`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00005006 ([`ctg-observation-nct00005006-2015-08-19-0369c5431f98`](#source-ctg-observation-nct00005006-2015-08-19-0369c5431f98))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00005006 at 2026-07-30T21:41:27.764Z. Its registry update date was 2015-08-19, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00005006-2015-08-19-0369c5431f98`](#source-ctg-observation-nct00005006-2015-08-19-0369c5431f98))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00005006 at 2026-07-30T21:41:27.764Z. Its registry update date was 2015-08-19, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00005006-2015-08-19-0369c5431f98`](#source-ctg-observation-nct00005006-2015-08-19-0369c5431f98))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00005006-2015-08-19-0369c5431f98`](#source-ctg-observation-nct00005006-2015-08-19-0369c5431f98))

## Sources

<a id="source-ctg-observation-nct00005006-2015-08-19-0369c5431f98"></a>
- **ClinicalTrials.gov record NCT00005006 · retained source version 2015-08-19:0369c5431f98ed231855677838da7b673ed3b847606a76badce17f8fa55c216f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00005006) (`ctg-observation-nct00005006-2015-08-19-0369c5431f98`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00005006." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00005006-teriparatide-v1.json SHA-256: 8afb1233b4a0726c0125905d67caf2994fb6c467fa963c06d8c4d13b5649a4a3.